Navigation Links
Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
Date:3/4/2011

HAVERFORD, Pa., March 4, 2011 /PRNewswire-USNewswire/ -- On March 3, 2011, the United States District Court for the Northern District of Ohio granted preliminary approval to a proposed settlement reached in a class action lawsuit filed by Chimicles & Tikellis LLP ("C&T") against STERIS Corporation ("STERIS").  The lawsuit is related to STERIS' marketing and sale of the STERIS SYSTEM 1® Sterile Processor (the "SS1 Device"), a tabletop liquid chemical system that provides rapid, low-temperature processing of surgical instruments such as endoscopes and bronchoscopes.  

Sterilization systems like the SS1 Device must be cleared by the FDA before they can be sold to healthcare providers.  The FDA cleared the SS1 in 1988.  The lawsuit filed by C&T alleges that STERIS made several material changes to the SS1 Device after 1988 without obtaining the necessary clearance from the FDA, and that as a result, the FDA informed healthcare providers that use of the SS1 Device "should be discontinued as soon as practicable," but no later than August 2, 2011.  STERIS subsequently entered into a consent decree with the FDA to implement a transition plan whereby healthcare providers could return their SS1 Devices to STERIS in exchange for a rebate (the "Rebate Program").  There are no allegations in this case that the SS1 Devices create a safety hazard, nor that anyone has been harmed as a result of using the SS1 Devices.

The proposed settlement of the class action lawsuit is on behalf of all domestic healthcare providers that own or owned a SS1 Device that was (a) purchased before January 1, 2009, and (b) in use on December 1, 2009.  SS1 Devices purchased after January 1, 2009 are not part of this proposed settlement because they are already eligible for a full refund from STERIS under the Rebate Program.  In December 2009, STERIS prepared a list of SS1 Devices then in use -- the "Transition List."  All eligi
'/>"/>

SOURCE Chimicles & Tikellis LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. German High Court Rules in Favor of AmniSure® as New European Guidelines Published
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
4. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
5. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
6. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
7. Sensipar® Patents Upheld By District Court
8. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
9. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
10. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
11. Statement of Ben Anderson, Esq., Regarding Denial of Wyeths En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented effort to ... TB in ambulances and other transport vehicles, an advanced and portable ... rescue personnel for the first time. In order ... with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
... , April 26 e-MDs, an industry leader ... and practice management (PM) solutions, announced they have been selected ... Alaska EHR Alliance (AEHRA).   e-MDs was identified through ... Alaska healthcare providers looking to incorporate an EHR in ...
... 26 Sirion Therapeutics, Inc., a privately held ophthalmic ... is now commercially available.  Zirgan™, which was approved by the ... is a topical ophthalmic antiviral indicated for the treatment of ... , , ...
Cached Medicine Technology:Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor 2Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor 3Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor 4Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 3
(Date:7/10/2014)... as tempting as full-fat equivalents could be heading ... how proteins can replace fats without affecting foodstuffs, ... Engineering and Physical Sciences Research Council (EPSRC), a ... Edinburgh has produced modified proteins that easily break ... behaviour of fats during food manufacture. The proteins ...
(Date:7/9/2014)... 2014 -- The World Health Organization recommends that youth ... to vigorous physical activity (MVPA) each day. Studies ... during school hours. Therefore, it stands to reason ... MVPA. In a new study scheduled for publication ... that time spent outdoors after school was positively associated ...
(Date:7/9/2014)... Perelman School of Medicine at the University of Pennsylvania ... received an $8 million grant from the National Cancer ... therapy (PDT) in patients with malignant pleural mesothelioma, a ... itself in the lining of the lungs and is ... will fund a clinical trial and additional studies looking ...
(Date:7/9/2014)... Studying the most common type of lung cancer, researchers ... a role in forming tumors. The new knowledge may ... these genetic changes already are available or are in ... , investigators from The Cancer Genome Atlas (TCGA), including ... Louis, Harvard Medical School and other institutions, studied tumors ...
(Date:7/9/2014)... used in policing injection drug users in Russia ... , A study, conducted by researchers from ... in collaboration with St. Petersburg Pavlov State University, ... on the health outcomes of a cohort of ... , Those who were arrested by police were ...
Breaking Medicine News(10 mins):Health News:Great tasting low-fat cheeses and cakes could soon be on the menu 2Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2
... triples risk of disease, study funds , , WEDNESDAY, ... to be predictors of esophageal cancer have been identified ... M. D. Anderson Cancer Center team pinpointed 11 single-nucleotide ... with esophageal cancer. , Each of these unfavorable genotypes ...
... Marketing Messages for Advair,and Xolair, According to a ... Nov. 5 Decision Resources one of the,world,s ... and,healthcare issues, finds that physicians and patients respond ... to use.,Physicians indicate that brands conveying messages of ...
... Stay Balanced Through the ... ... and New York Times best-selling author Ellie Krieger, of Food Network,fame, ... health. Yo-Plus contains live and active probiotic cultures,specifically designed for digestive ...
... PITTSBURGH, Nov. 5 CardiacAssist, Inc. announced that,it reached a ... System,performing at least one TandemHeart case during the third quarter ... highest year on,year growth in case activity with a leap ... 70 % and 497 %. Through nine months of 2008,CardiacAssist ...
... for passengers taking 7- to ... 9-hour flights, ... Minerva Cardioangiologica reveals Pycnogenol(R), pine bark,extract from the French maritime pine tree, ... a brain CT scan and a,scoring system, showed Pycnogenol(R) lowered symptoms of ...
... companies is often dependent on their ability to do deals ... A Comprehensive Assessment of Valuation in the Pharmaceutical Sector, the ... aspects of deal-making, including valuations and royalty rate calculations. ... ...
Cached Medicine News:Health News:Researchers ID Genetic Markers for Esophageal Cancer 2Health News:Physicians Rank Schering-Plough's Marketing Messages for Asmanex as the Most Appealing in the Asthma Drug Market 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 3Health News:CardiacAssist, Inc. Announces Record Breaking Site Activity and Financial Results 2Health News:Study Shows Pine Bark Reduces Jetlag 2Health News:Study Shows Pine Bark Reduces Jetlag 3Health News:Study Shows Pine Bark Reduces Jetlag 4Health News:Determining Valuations in Challenging Times 2Health News:Determining Valuations in Challenging Times 3Health News:Determining Valuations in Challenging Times 4
VG1 ALIF (Anterior Lateral) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Medicine Products: